<!doctype html><html lang=tw><head><meta charset=utf-8><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=viewport content="width=device-width,initial-scale=1"><meta name=referrer content="no-referrer"><link rel=dns-prefetch href=https://i.geekbank.cf/><title>2019 AACR | Kè—¥åœ¨å»£æ³›æœŸSCLCæ‚£è€…ä¸­é¡¯ç¤ºå‡ºä»¤äººé¼“èˆçš„æŠ—è…«ç˜¤æ´»æ€§å’ŒæŒä¹…åæ‡‰ | æå®¢å¿«è¨Š</title><meta property="og:title" content="2019 AACR | Kè—¥åœ¨å»£æ³›æœŸSCLCæ‚£è€…ä¸­é¡¯ç¤ºå‡ºä»¤äººé¼“èˆçš„æŠ—è…«ç˜¤æ´»æ€§å’ŒæŒä¹…åæ‡‰ - æå®¢å¿«è¨Š"><meta property="og:type" content="article"><meta property="og:locale" content="tw"><meta property="og:image" content="https://p3.pstatp.com/large/pgc-image/RMO1D3wIM6bQ5S"><link rel=alternate hreflang=x-default href=https://geekbank.cf/tw/%e7%a7%91%e6%8a%80/8cb2a5eb.html><link rel=alternate hreflang=zh-tw href=https://geekbank.cf/tw/%e7%a7%91%e6%8a%80/8cb2a5eb.html><link rel=alternate hreflang=zh-cn href=https://geekbank.cf/cn/%e7%a7%91%e6%8a%80/8cb2a5eb.html><link rel=alternate hreflang=zh-hk href=https://geekbank.cf/tw/%e7%a7%91%e6%8a%80/8cb2a5eb.html><link rel=alternate hreflang=zh-mo href=https://geekbank.cf/tw/%e7%a7%91%e6%8a%80/8cb2a5eb.html><link rel=alternate hreflang=zh-my href=https://geekbank.cf/cn/%e7%a7%91%e6%8a%80/8cb2a5eb.html><link rel=alternate hreflang=zh-sg href=https://geekbank.cf/cn/%e7%a7%91%e6%8a%80/8cb2a5eb.html><link rel=canonical href=https://geekbank.cf/tw/%e7%a7%91%e6%8a%80/8cb2a5eb.html><meta property="article:published_time" content="2020-11-14T21:02:05+08:00"><meta property="article:modified_time" content="2020-11-14T21:02:05+08:00"><meta name=Keywords content><meta name=description content="2019 AACR | Kè—¥åœ¨å»£æ³›æœŸSCLCæ‚£è€…ä¸­é¡¯ç¤ºå‡ºä»¤äººé¼“èˆçš„æŠ—è…«ç˜¤æ´»æ€§å’ŒæŒä¹…åæ‡‰"><meta name=author content="æå®¢å¿«è¨Š"><meta property="og:url" content="/tw/%E7%A7%91%E6%8A%80/8cb2a5eb.html"><link rel=apple-touch-icon sizes=180x180 href=../../apple-touch-icon.png><link rel=icon type=image/png sizes=32x32 href=../../favicon-32x32.png><link rel=icon type=image/png sizes=16x16 href=../../favicon-16x16.png><link rel=manifest href=../../site.webmanifest><link rel=mask-icon href=../../safari-pinned-tab.svg color=#5bbad5><meta name=msapplication-TileColor content="#ffc40d"><meta name=theme-color content="#ffffff"><link rel=stylesheet href=https://geekbank.cf/css/normalize.css><link rel=stylesheet href=https://geekbank.cf/css/style.css><script type=text/javascript src=https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js></script><script type=text/javascript src=https://geekbank.cf/js/jqthumb.min.js></script><script data-ad-client=ca-pub-3525055026201463 async src=https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js></script></head><body><header id=header class=clearfix><div class=container><div class=col-group><div class=site-name><h1><a id=logo href>ğŸ¤“ æå®¢å¿«è¨Š Geek Bank</a></h1><p class=description>ç‚ºä½ å¸¶ä¾†æœ€å…¨çš„ç§‘æŠ€çŸ¥è­˜ ğŸ§¡</p></div><div><nav id=nav-menu class=clearfix><a class=current href>çŒœä½ å–œæ­¡</a>
<a href=../../tw/categories/%E7%A7%91%E6%8A%80.html title=ç§‘æŠ€>ç§‘æŠ€</a>
<a href=../../tw/categories/%E9%81%8A%E6%88%B2.html title=éŠæˆ²>éŠæˆ²</a>
<a href=../../tw/categories/%E7%A7%91%E5%AD%B8.html title=ç§‘å­¸>ç§‘å­¸</a></nav></div></div></div></header><div id=body><div class=container><div class=col-group><div class=col-8 id=main><div class=res-cons><article class=post><header><h1 class=post-title>2019 AACR | Kè—¥åœ¨å»£æ³›æœŸSCLCæ‚£è€…ä¸­é¡¯ç¤ºå‡ºä»¤äººé¼“èˆçš„æŠ—è…«ç˜¤æ´»æ€§å’ŒæŒä¹…åæ‡‰</h1></header><date class="post-meta meta-date">2020-11-14</date><div class=post-meta><span>|</span>
<span class=meta-category><a href=tw/categories/%E7%A7%91%E6%8A%80.html>ç§‘æŠ€</a></span></div><div class=post-content><img alt="2019 AACR | Kè—¥åœ¨å»£æ³›æœŸSCLCæ‚£è€…ä¸­é¡¯ç¤ºå‡ºä»¤äººé¼“èˆçš„æŠ—è…«ç˜¤æ´»æ€§å’ŒæŒä¹…åæ‡‰" onerror=errorimg.call(this); src=https://p3.pstatp.com/large/pgc-image/RMO1D3wIM6bQ5S><p>2019å¹´ç¾åœ‹ç™Œç—‡ç ”ç©¶å”æœƒ(AACR)å¹´æœƒæ–¼2019å¹´3æœˆ29æ—¥â€”4æœˆ3æ—¥åœ¨ç¾åœ‹äºç‰¹è˜­å¤§èˆ‰è¡Œã€‚AACRå¹´æœƒæ˜¯ä¸–ç•Œä¸Šè¦æ¨¡æœ€å¤§çš„ç™Œç—‡ç ”ç©¶æœƒè­°ä¹‹ä¸€ï¼Œä»Šå¹´AACRå¤§æœƒä¸»é¡Œç‚ºâ€œç¶œåˆæ€§ç™Œç—‡ç§‘å­¸â€¢å…¨çƒå½±éŸ¿â€¢å€‹æ€§åŒ–æ‚£è€…è­·ç†â€ã€‚å…ç–«ç™‚æ³•ä¾èˆŠæ˜¯ä»Šå¹´AACRçš„ä¸€å€‹é‡è¦ä¸»é¡Œã€‚</p><p>3æœˆ28æ—¥ï¼Œå¸•åšåˆ©ç å–®æŠ—ï¼ˆKè—¥ï¼‰ä¸€ç·šæ²»ç™‚è½‰ç§»æ€§éé±—ç‹€éå°ç´°èƒè‚ºç™Œï¼ˆNSCLCï¼‰çš„é©æ‡‰è­‰æ­£å¼ç²æ‰¹ã€‚é€™ä¸€é‡ç£…æ¶ˆæ¯çš„é¤˜ç†±é‚„æœªæ•£å»ï¼Œå¸•åšåˆ©ç å–®æŠ—çš„åˆä¸€åˆ©å¥½æ¶ˆæ¯åœ¨2019å¹´çš„AACRå¹´æœƒä¸Šè¢«å…¬ä½ˆã€‚</p><p>ç¾åœ‹ç•¶åœ°æ™‚é–“4æœˆ1æ—¥åˆé–“ï¼ŒéŸ“åœ‹å»¶ä¸–å¤§å­¸é†«å­¸é™¢å»¶ä¸–ç™Œç—‡ä¸­å¿ƒHyun Cheol Chungæ•™æˆå…¬ä½ˆäº†KEYNOTE-028å’ŒKEYNOTE-158è©¦é©—çš„å½™ç¸½åˆ†æï¼Œåˆ†æçµæœé¡¯ç¤ºï¼Œå¸•åšåˆ©ç å–®æŠ—åœ¨é è™•ç†çš„æ™šæœŸå°ç´°èƒè‚ºç™Œï¼ˆSCLCï¼‰æ‚£è€…ä¸­è¡¨ç¾å‡ºä»¤äººé¼“èˆçš„æŠ—è…«ç˜¤æ´»æ€§å’ŒæŒä¹…åæ‡‰ã€‚</p><p><strong>ç ”ç©¶æ–¹æ³•</strong></p><p>è©²å½™ç¸½åˆ†æåƒ…é—œæ³¨KEYNOTE-028è©¦é©—ä¸­çš„IbæœŸå’ŒKEYNOTE-158ä¸­çš„IIæœŸè©¦é©—çš„SCLCéšŠåˆ—ï¼Œä¸¦å°ç¬¦åˆç´å…¥åˆ†æè¦æ±‚çš„æ‚£è€…é€²è¡Œäº†çµ„ç¹”å­¸æˆ–ç´°èƒå­¸è­‰å¯¦ï¼Œä¿è­‰å…¶æ»¿è¶³ç„¡æ³•æ²»ç™’çš„æ™šæœŸSCLCï¼Œæ¨™æº–æ²»ç™‚é€²å±•æˆ–å¤±æ•—ï¼Œä¸”æœªæ¥å—å…ç–«æ²»ç™‚çš„æ¢ä»¶ã€‚</p><p>å…©é …è©¦é©—å…±ç´å…¥131ä¾‹SCLCæ‚£è€…ï¼ŒåŒ…æ‹¬ä¾†è‡ªKEYNOTE-028çš„24åæ‚£è€…å’Œä¾†è‡ªKEYNOTE-158çš„107åæ‚£è€…ã€‚å…¶ä¸­ï¼Œ83åæ¥å—éâ‰¥2æ¬¡æ²»ç™‚çš„æ‚£è€…è¢«ç¢ºå®šæœ‰è³‡æ ¼é€²è¡Œç™‚æ•ˆåˆ†æã€‚é›–ç„¶åƒåŠ KEYNOTE-028è©¦é©—çš„æ‚£è€…éœ€è¦æ‚£æœ‰PD-L1é™½æ€§è…«ç˜¤ï¼ˆç¶œåˆé™½æ€§è©•åˆ†â‰¥1ï¼‰ï¼Œä½†é€™ä¸æ˜¯ç™»è¨˜KEYNOTE-158æ‰€å¿…éœ€çš„ã€‚</p><p>åœ¨KEYNOTE-028ä¸­æ¯8å‘¨é€²è¡Œä¸€æ¬¡æ”¾å°„æˆåƒï¼ŒKEYNOTE-158ä¸­å‰‡æ¯9å‘¨é€²è¡Œä¸€æ¬¡ï¼›KEYNOTE-028ä¸­6å€‹æœˆå¾Œæ¯12å‘¨é€²è¡Œä¸€æ¬¡ï¼ŒKEYNOTE-158ä¸­å‰‡åœ¨é€²è¡Œ1å¹´å¾Œå†æ”¹ç‚ºæ¯12é€±ä¸€æ¬¡ã€‚è©¦åŠ‘çš„åŠ‘é‡åœ¨å…©é …è©¦é©—ä¸­ä¹Ÿå­˜åœ¨å·®åˆ¥ã€‚åœ¨KEYNOTE-028ä¸­æ¯2å‘¨çµ¦äºˆå¸•åšåˆ©ç å–®æŠ— 10mg / kgï¼Œè€Œåœ¨KEYNOTE-158ä¸­å‰‡æ˜¯æ¯3å‘¨çµ¦äºˆ200mgåŠ‘é‡ã€‚çµ¦è—¥åŠ‘æŒçºŒ2å¹´æˆ–ç›´è‡³ç–¾ç—…é€²å±•æˆ–æ¯’æ€§ä¸èƒ½è€å—å‰‡çµ‚æ­¢ã€‚</p><p>å…©é …ç ”ç©¶çš„ä¸»è¦çµ‚é»æ˜¯ç›¸åŒçš„ï¼šç¸½ç·©è§£ç‡ï¼ˆORRï¼‰ï¼Œæ ¹æ“šRECIST 1.1æ¨™æº–è©•ä¼°ã€‚ç·©è§£æŒçºŒæ™‚é–“ï¼ˆDORï¼‰ï¼Œç„¡é€²å±•ç”Ÿå­˜æœŸï¼ˆPFSï¼‰å’Œç¸½ç”Ÿå­˜æœŸï¼ˆOSï¼‰å‡ä½œç‚ºæ¬¡è¦çµ‚é»ï¼Œä¸¦ä¸”ä½¿ç”¨Kaplan-Meieræ–¹æ³•é€²è¡Œä¼°è¨ˆã€‚</p><p><strong>ç ”ç©¶çµæœ</strong></p><p>ä¾†è‡ªKEYNOTE-028çš„æ•¸æ“šé¡¯ç¤ºORRç‚º33.3%ï¼ˆ95%CIï¼Œ15.6%-55.3%ï¼‰å’ŒDORç‚º19.4å€‹æœˆï¼ˆ3.6 +è‡³20.0+ï¼‰ã€‚å°±ç”Ÿå­˜ç²ç›Šè€Œè¨€ï¼Œä½¿ç”¨å¸•åšåˆ©ç å–®æŠ—æ²»ç™‚å¾Œï¼Œæ‚£è€…çš„ä¸­ä½PFSç‚º1.9å€‹æœˆï¼ˆ95%CIï¼Œ1.7-5.9ï¼‰ï¼Œä¸­ä½OSç‚º9.7å€‹æœˆï¼ˆ95%CIï¼Œ4.1-æœªé”åˆ°ï¼‰ã€‚ç›¸æ¯”ä¹‹ä¸‹ï¼Œåœ¨IIæœŸKEYNOTE-158è©¦é©—ä¸­ç”¨PD-1æŠ‘åˆ¶åŠ‘è§€å¯Ÿåˆ°çš„ORRç‚º18.7%ï¼ˆ95%CIï¼Œ11.8%-27.4%ï¼‰ï¼Œè€ŒDORå°šæœªé”åˆ°ï¼ˆ2.1+è‡³18.7+ï¼‰ã€‚è©²è©¦é©—çš„ä¸­ä½PFSå’ŒOSåˆ†åˆ¥ç‚º2.0å€‹æœˆï¼ˆ95%CIï¼Œ1.9-2.1ï¼‰å’Œ8.7å€‹æœˆï¼ˆ95%CIï¼Œ5.6-12.0ï¼‰ã€‚</p><p>å½™ç¸½åˆ†æçµæœé¡¯ç¤ºï¼ŒORRç‚º19.3%ï¼ˆ16ä¾‹æ‚£è€…ï¼›95%CIï¼Œ11.4%-29.4%ï¼‰ï¼Œå…¶ä¸­2ä¾‹æ‚£è€…ï¼ˆ2%ï¼‰é”åˆ°å®Œå…¨ç·©è§£ï¼Œ14ä¾‹æ‚£è€…ï¼ˆ17%ï¼‰éƒ¨åˆ†ç·©è§£ï¼Œ15ä¾‹æ‚£è€…ç—…æƒ…ç©©å®šï¼ˆ18%ï¼‰ã€‚9åå—è¨ªè€…ï¼ˆ61%ï¼‰çš„DORâ‰¥18å€‹æœˆã€‚</p><p>ä¸­ä½éš¨è¨ªæ™‚é–“ç‚º7.7å€‹æœˆï¼ˆ0.5-48.7ï¼‰ï¼Œç ”ç©¶è€…è§€å¯Ÿåˆ°ä¸­ä½PFSç‚º2å€‹æœˆï¼ˆ95%CIï¼Œ1.9-3.4ï¼‰ï¼Œä¸­ä½OSç‚º7.7å€‹æœˆï¼ˆ95%CIï¼Œ5.2-10.1ï¼‰ã€‚åœ¨12å€‹æœˆçš„éš¨è¨ªä¸­ï¼ŒPFSç‡ç‚º17%ï¼Œè€ŒOSç‡ç‚º34%ï¼›åœ¨24å€‹æœˆæ™‚ï¼ŒPFSå’ŒOSç‡åˆ†åˆ¥ç‚º13%å’Œ21%ã€‚</p><p>å€¼å¾—æ³¨æ„çš„æ˜¯ï¼Œ16åç·©è§£è€…ä¸­æœ‰14åPD-L1é™½æ€§ã€‚ç”±æ–¼å…©é …è©¦é©—æœ‰ä¸åŒçš„è©•ä¼°PD-L1çš„æ–¹æ³•ï¼Œåƒèˆ‡å½™ç¸½åˆ†æçš„ç ”ç©¶è€…ä¸¦ä¸æ‰“ç®—è©•ä¼°PD-L1é™½æ€§åœ¨æ‚£è€…é¸æ“‡ä¸­çš„ä½œç”¨ã€‚</p><p>åœ¨åˆ†æä¸­è§€å¯Ÿåˆ°ä¸è‰¯äº‹ä»¶ï¼ˆAEï¼‰èˆ‡å…ˆå‰é—œæ–¼æŠ—PD-1å–®å…‹éš†æŠ—é«”çš„å®‰å…¨æ€§ç‰¹å¾µçš„å ±é“ä¸€è‡´ã€‚åœ¨KEYNOTE-028å’ŒKEYNOTE-158å…©é …è©¦é©—çš„æ‰€æœ‰SCLCæ‚£è€…ï¼ˆN = 131ï¼‰ä¸­ï¼Œä¸è€ƒæ…®å…ˆå‰çš„æ²»ç™‚ï¼Œ8%å‡ºç¾3ç´šæ²»ç™‚ç›¸é—œçš„AEï¼ˆæ²’æœ‰4ç´šæ²»ç™‚ç›¸é—œçš„AEï¼‰ï¼Œ3åæ‚£è€…å‡ºç¾5ç´šæ²»ç™‚ç›¸é—œçš„AEï¼ˆè…¸ç¼ºè¡€ã€è‚ºç‚ã€è…¦ç—…ï¼‰ã€‚21%çš„æ‚£è€…ç¶“æ­·éå…ç–«ä»‹å°çš„AEæˆ–è¼¸æ³¨åæ‡‰ã€‚</p><p><strong>çµè«–</strong></p><p>å¸•åšåˆ©ç å–®æŠ—åœ¨æ¥å—éå…©æ¬¡æˆ–æ›´å¤šæ¬¡æ²»ç™‚çš„å»£æ³›æœŸSCLCæ‚£è€…ä¸­é¡¯ç¤ºå‡ºä»¤äººé¼“èˆçš„æŠ—è…«ç˜¤æ´»æ€§ï¼Œä¸”åæ‡‰æŒä¹…ï¼Œå¤§å¤šæ•¸æ‚£è€…çš„ç·©è§£æŒçºŒæ™‚é–“è‡³å°‘ç‚º18å€‹æœˆï¼Œä¸¦æ²’æœ‰è§€å¯Ÿåˆ°å¸•åšåˆ©ç å–®æŠ—é æœŸä»¥å¤–çš„æ¯’æ€§ã€‚</p><p><strong>è‹±æ–‡æ‘˜è¦</strong></p><p><strong>Background: </strong>The antitumor activity of the anti-PD-1 monoclonal antibody pembrolizumab in patients with advanced SCLC has been evaluated in the Phase Ib basket study KEYNOTE-028 (KN028; NCT02054806) and in the Phase II basket study KEYNOTE-158 (KN158; NCT02628067). We present outcomes for patients enrolled in KN028 and KN158 who were receiving pembrolizumab after â‰¥2 lines of prior therapy.</p><p><strong>Methods:</strong>Eligible patients had histologically/cytologically confirmed incurable advanced SCLC, measurable disease per RECIST 1.1, ECOG PS of 0/1, had experienced progression/failure on standard therapy, and were immunotherapy-naive; patients included in this analysis had received â‰¥2 lines of systemic therapy. Patients in KN028 were required to have PD-L1-positive tumors (membranous PD-L1 expression in â‰¥1% of tumor and associated inflammatory cells or positive staining in stroma); tumor PD-L1 expression was not required in KN158. Radiographic imaging was performed Q8W for 6 mo (KN028) or Q9W for 1 y (KN158), and Q12W thereafter. Pembrolizumab (10 mg/kg Q2W [KN028] or 200 mg Q3W [KN158]) was administered for 2 y or until disease progression or intolerable toxicity. The primary endpoint in both studies was objective response rate (ORR) assessed per RECIST 1.1. Duration of response (DOR), progression-free survival (PFS), and overall survival (OS) were secondary endpoints and estimated using the Kaplan-Meier method. For this analysis, assessment of response was by independent central review.</p><p><strong>Results:</strong>Of 131 SCLC pts included in both trials, 83 were eligible for efficacy analyses (KN158, n=64; KN028, n=19). Median age was 62 (range, 24â€’84) y, 64% were men, and 36% had received â‰¥3 lines of systemic therapy. As of the data cutoff date, median follow-up was 7.7 (range, 0.5â€’48.7) mo. The ORR was 19.3% (95% CI, 11.4-29.4). Two patients had a complete response and 14 had a partial response per independent central review; 14 of 16 responders were PD-L1-positive. Median DOR was not reached (range, 4.1-35.8 [ongoing] mo). 9 of 16 responders (61% per Kaplan-Meier estimate) had response lasting â‰¥18 mo. Median PFS was 2.0 (95% CI, 1.9-3.4) mo and median OS was 7.7 (95% CI, 5.2-10.1) mo. 12- and 24-month rates were 16.9% and 13.1% for PFS, and 34% and 21% for OS. Among all SCLC patients in KN028 and KN158 irrespective of prior therapies (N=131), 8% had a grade 3 treatment-related AE (no grade 4 treatment-related AEs). 3 patients had grade 5 treatment-related AEs (intestinal ischemia, pneumonia, encephalopathy). 21% experienced an immune-mediated AE or infusion reaction.</p><p><strong>Conclusions: </strong>Pembrolizumab demonstrated promising antitumor activity in patients with advanced SCLC who had received â‰¥2 lines of prior therapy. Responses were durable, with the majority of patients estimated to have a response duration of at least 18 mo. No unexpected toxicities from pembrolizumab were observed.</p><p>åƒè€ƒä¾†æºï¼š</p><p>[1] Pembrolizumab after two or more lines of prior therapy in patients with advanced small-cell lung cancer (SCLC): Results from the KEYNOTE-028 and KEYNOTE-158 studies. Abstract CT073</p><p>[2] Pembrolizumab Shows Promising Antitumor Activity in Pretreated Patients with SCLC. Onclive/Conference-coverage/AACR-2019.Tuesday, Apr 02, 2019</p><p>2019 AACR å°ˆé¡Œ</p><p>é•·æŒ‰è­˜åˆ¥äºŒç¶­ç¢¼æŸ¥çœ‹</p></div><div class="post-meta meta-tags"><ul class=clearfix><li><a>2019</a></li><li><a>AACR</a></li><li><a>è—¥åœ¨</a></li></ul></div></article></div></div><div id=secondary><section class=widget><form id=search action=//www.google.com/search method=get accept-charset=utf-8 target=_blank _lpchecked=1><input type=text name=q maxlength=20 placeholder=æœç´¢>
<input type=hidden name=sitesearch value=geekbank.cf>
<button type=submit>ğŸ”</button></form></section><section class=widget><h3 class=widget-title>æœ€æ–°æ–‡ç«  âš¡</h3><ul class=widget-list><li><a href=../../tw/%E7%A7%91%E6%8A%80/21d2ba3e.html alt=2019å¹´åœŸæœ¨ç•¢æ¥­ç”Ÿè¦çŸ¥é“çš„é‚£äº›äº‹ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/21d2ba3e.html title=2019å¹´åœŸæœ¨ç•¢æ¥­ç”Ÿè¦çŸ¥é“çš„é‚£äº›äº‹>2019å¹´åœŸæœ¨ç•¢æ¥­ç”Ÿè¦çŸ¥é“çš„é‚£äº›äº‹</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/171b22b4.html alt=2019å¹´åº¦ã€Šç‰¹ç¨®é‘„é€ åŠæœ‰è‰²åˆé‡‘ã€‹å„ªç§€è«–æ–‡çµæœå…¬ä½ˆ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p9.pstatp.com/large/137c70000b816835d80bf style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/171b22b4.html title=2019å¹´åº¦ã€Šç‰¹ç¨®é‘„é€ åŠæœ‰è‰²åˆé‡‘ã€‹å„ªç§€è«–æ–‡çµæœå…¬ä½ˆ>2019å¹´åº¦ã€Šç‰¹ç¨®é‘„é€ åŠæœ‰è‰²åˆé‡‘ã€‹å„ªç§€è«–æ–‡çµæœå…¬ä½ˆ</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/817e1015.html alt=2019å¹´åº¦ã€Šç‰¹ç¨®é‘„é€ åŠæœ‰è‰²åˆé‡‘ã€‹ç¶²çµ¡è©•é¸çµæœå‡ºçˆ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p9.pstatp.com/large/pgc-image/66c26cbe459a4361b1d501e4bbac6c88 style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/817e1015.html title=2019å¹´åº¦ã€Šç‰¹ç¨®é‘„é€ åŠæœ‰è‰²åˆé‡‘ã€‹ç¶²çµ¡è©•é¸çµæœå‡ºçˆ>2019å¹´åº¦ã€Šç‰¹ç¨®é‘„é€ åŠæœ‰è‰²åˆé‡‘ã€‹ç¶²çµ¡è©•é¸çµæœå‡ºçˆ</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/df18bcc1.html alt=é‡‘å·é›†åœ˜å…¬å¸2019å¹´å…¨åœ‹åˆé‡‘é‘„é€ è¡Œæ¥­å•†æ´½æœƒèˆ‰è¡Œ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/df18bcc1.html title=é‡‘å·é›†åœ˜å…¬å¸2019å¹´å…¨åœ‹åˆé‡‘é‘„é€ è¡Œæ¥­å•†æ´½æœƒèˆ‰è¡Œ>é‡‘å·é›†åœ˜å…¬å¸2019å¹´å…¨åœ‹åˆé‡‘é‘„é€ è¡Œæ¥­å•†æ´½æœƒèˆ‰è¡Œ</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/3c5292d6.html alt="2019å¹´åº¦æ•¸å­—å­¿ç”ŸåŸå¸‚ä¹‹ç„¡äººæ©Ÿ èˆªæ”æ‡‰ç”¨åŠçœŸä¸‰ç¶­å»ºæ¨¡æŠ€è¡“åŸ¹è¨“ç­" class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/3c5292d6.html title="2019å¹´åº¦æ•¸å­—å­¿ç”ŸåŸå¸‚ä¹‹ç„¡äººæ©Ÿ èˆªæ”æ‡‰ç”¨åŠçœŸä¸‰ç¶­å»ºæ¨¡æŠ€è¡“åŸ¹è¨“ç­">2019å¹´åº¦æ•¸å­—å­¿ç”ŸåŸå¸‚ä¹‹ç„¡äººæ©Ÿ èˆªæ”æ‡‰ç”¨åŠçœŸä¸‰ç¶­å»ºæ¨¡æŠ€è¡“åŸ¹è¨“ç­</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/fcd2a59f.html alt=2019å¹´æœ€çˆ†ç¬‘çš„120å€‹åå ´é¢åˆé›† class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/dc6fcd05f35e499a9ef7a2d19ff9c66b style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/fcd2a59f.html title=2019å¹´æœ€çˆ†ç¬‘çš„120å€‹åå ´é¢åˆé›†>2019å¹´æœ€çˆ†ç¬‘çš„120å€‹åå ´é¢åˆé›†</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/715eacc1.html alt=ã€Šç…å­ç‹ã€‹2019ï¼šå¼•å…¥VRè™›æ“¬è£½ä½œæŠ€è¡“ï¼Œé¡›è¦†å‹•ç•«é›»å½±æ‹æ” class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/9a08cc2f25cb41c5be515de0d79879a9 style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/715eacc1.html title=ã€Šç…å­ç‹ã€‹2019ï¼šå¼•å…¥VRè™›æ“¬è£½ä½œæŠ€è¡“ï¼Œé¡›è¦†å‹•ç•«é›»å½±æ‹æ”>ã€Šç…å­ç‹ã€‹2019ï¼šå¼•å…¥VRè™›æ“¬è£½ä½œæŠ€è¡“ï¼Œé¡›è¦†å‹•ç•«é›»å½±æ‹æ”</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/e342e11c.html alt="2019æŒä¸Šç”Ÿæ´»10å…ƒé¢¨æš´æ€éº¼ç©æ”»ç•¥ å¿«é€Ÿç²å–å°æ‹›å–µæ–¹æ³•" class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/Rk8ZSn39iz0Be8 style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/e342e11c.html title="2019æŒä¸Šç”Ÿæ´»10å…ƒé¢¨æš´æ€éº¼ç©æ”»ç•¥ å¿«é€Ÿç²å–å°æ‹›å–µæ–¹æ³•">2019æŒä¸Šç”Ÿæ´»10å…ƒé¢¨æš´æ€éº¼ç©æ”»ç•¥ å¿«é€Ÿç²å–å°æ‹›å–µæ–¹æ³•</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/67fef4c6.html alt=2019å¹´é«˜è€ƒï¼Œæ€æ¨£è¨­ç½®é™¢æ ¡æ¢¯åº¦æ‰åˆç†ï¼Ÿè¡ã€ç©©ã€ä¿ã€å¢Šï¼Œå¾ˆé—œéµï¼ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p3.pstatp.com/large/dfic-imagehandler/f8d17716-f3b8-4c6d-8eb7-f482334ad491 style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/67fef4c6.html title=2019å¹´é«˜è€ƒï¼Œæ€æ¨£è¨­ç½®é™¢æ ¡æ¢¯åº¦æ‰åˆç†ï¼Ÿè¡ã€ç©©ã€ä¿ã€å¢Šï¼Œå¾ˆé—œéµï¼>2019å¹´é«˜è€ƒï¼Œæ€æ¨£è¨­ç½®é™¢æ ¡æ¢¯åº¦æ‰åˆç†ï¼Ÿè¡ã€ç©©ã€ä¿ã€å¢Šï¼Œå¾ˆé—œéµï¼</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/e18c5b5e.html alt=2019å¹´æ­£åœ¨æµè¡Œçš„16å€‹ç¶²é è¨­è¨ˆè¶¨å‹¢ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/RPgQdSQEjBTN6Z style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/e18c5b5e.html title=2019å¹´æ­£åœ¨æµè¡Œçš„16å€‹ç¶²é è¨­è¨ˆè¶¨å‹¢>2019å¹´æ­£åœ¨æµè¡Œçš„16å€‹ç¶²é è¨­è¨ˆè¶¨å‹¢</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/d72ed228.html alt=2019å¹´ä¸­å¼çƒ¹èª¿å¸«ï¼ˆæŠ€å¸«ï¼‰å®‰å…¨ç”Ÿç”¢æ¨¡æ“¬è€ƒè©¦é¡Œåº«åŠç­”æ¡ˆï¼ˆä¸€ï¼‰ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/fbcf9bc4d8224c309106305ad34adf9a style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/d72ed228.html title=2019å¹´ä¸­å¼çƒ¹èª¿å¸«ï¼ˆæŠ€å¸«ï¼‰å®‰å…¨ç”Ÿç”¢æ¨¡æ“¬è€ƒè©¦é¡Œåº«åŠç­”æ¡ˆï¼ˆä¸€ï¼‰>2019å¹´ä¸­å¼çƒ¹èª¿å¸«ï¼ˆæŠ€å¸«ï¼‰å®‰å…¨ç”Ÿç”¢æ¨¡æ“¬è€ƒè©¦é¡Œåº«åŠç­”æ¡ˆï¼ˆä¸€ï¼‰</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/d4044e1f.html alt=2019å¹´ä¸­å¼çƒ¹èª¿å¸«ï¼ˆé«˜ç´šï¼‰å®‰å…¨ç”Ÿç”¢æ¨¡æ“¬è€ƒè©¦é¡Œåº«åŠç­”æ¡ˆï¼ˆä¸€ï¼‰ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/d4044e1f.html title=2019å¹´ä¸­å¼çƒ¹èª¿å¸«ï¼ˆé«˜ç´šï¼‰å®‰å…¨ç”Ÿç”¢æ¨¡æ“¬è€ƒè©¦é¡Œåº«åŠç­”æ¡ˆï¼ˆä¸€ï¼‰>2019å¹´ä¸­å¼çƒ¹èª¿å¸«ï¼ˆé«˜ç´šï¼‰å®‰å…¨ç”Ÿç”¢æ¨¡æ“¬è€ƒè©¦é¡Œåº«åŠç­”æ¡ˆï¼ˆä¸€ï¼‰</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/f855d5ae.html alt=2019å¹´ä¸­å¼çƒ¹èª¿å¸«ï¼ˆé«˜ç´šï¼‰å®‰å…¨ç”Ÿç”¢æ¨¡æ“¬è€ƒè©¦é¡Œåº«åŠç­”æ¡ˆï¼ˆäºŒï¼‰ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/9796cfd44f754f9ab22310d91088423e style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/f855d5ae.html title=2019å¹´ä¸­å¼çƒ¹èª¿å¸«ï¼ˆé«˜ç´šï¼‰å®‰å…¨ç”Ÿç”¢æ¨¡æ“¬è€ƒè©¦é¡Œåº«åŠç­”æ¡ˆï¼ˆäºŒï¼‰>2019å¹´ä¸­å¼çƒ¹èª¿å¸«ï¼ˆé«˜ç´šï¼‰å®‰å…¨ç”Ÿç”¢æ¨¡æ“¬è€ƒè©¦é¡Œåº«åŠç­”æ¡ˆï¼ˆäºŒï¼‰</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/9adee5f1.html alt=2019ä¸­å¼çƒ¹èª¿å¸«ï¼ˆæŠ€å¸«ï¼‰åœ¨ç·šå…è²»æ¨¡æ“¬è€ƒè©¦ç³»çµ±åŠæ¨¡æ“¬é¡Œåº«2 class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/d6a75905fb9346ccb6e4c8a304a79e63 style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/9adee5f1.html title=2019ä¸­å¼çƒ¹èª¿å¸«ï¼ˆæŠ€å¸«ï¼‰åœ¨ç·šå…è²»æ¨¡æ“¬è€ƒè©¦ç³»çµ±åŠæ¨¡æ“¬é¡Œåº«2>2019ä¸­å¼çƒ¹èª¿å¸«ï¼ˆæŠ€å¸«ï¼‰åœ¨ç·šå…è²»æ¨¡æ“¬è€ƒè©¦ç³»çµ±åŠæ¨¡æ“¬é¡Œåº«2</a></li><hr><li><a href=../../tw/%E7%A7%91%E6%8A%80/01e18262.html alt="2019ç´šè»è¨“ | è›»è®Šä¸­çš„æˆé•·ï¼Œåœ¨è¥¿äº¬å­¸é™¢æˆ‘å€‘ä¸€èµ·ç¶“æ­·çš„è»è¨“" class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p3.pstatp.com/large/pgc-image/5e6d48b6fc5a49f480f9de7e22ab7958 style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E6%8A%80/01e18262.html title="2019ç´šè»è¨“ | è›»è®Šä¸­çš„æˆé•·ï¼Œåœ¨è¥¿äº¬å­¸é™¢æˆ‘å€‘ä¸€èµ·ç¶“æ­·çš„è»è¨“">2019ç´šè»è¨“ | è›»è®Šä¸­çš„æˆé•·ï¼Œåœ¨è¥¿äº¬å­¸é™¢æˆ‘å€‘ä¸€èµ·ç¶“æ­·çš„è»è¨“</a></li><hr></ul></section><section class=widget><h3 class=widget-title>å…¶ä»–</h3><ul class=widget-list><li><a href=TOS.html>ä½¿ç”¨æ¢æ¬¾</a></li><li><a href=CommentPolicy.html>ç•™è¨€æ”¿ç­–</a></li><li><a href=mailto:gdnews@tuta.io rel=nofollow>DMCA</a></li><li><a href=mailto:gdnews@tuta.io rel=nofollow>è¯çµ¡æˆ‘å€‘</a></li></ul></section></div></div></div></div><footer id=footer><div class=container>&copy; 2020 <a href>æå®¢å¿«è¨Š</a></div></footer><script type=text/javascript>window.MathJax={tex2jax:{inlineMath:[['$','$']],processEscapes:true}};</script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-MML-AM_CHTML" async></script><a id=rocket href=#top></a><script type=text/javascript src=https://kknews.cf/js/totop.js async></script><script type=text/javascript src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-5e508ed9e4e698bb"></script></body></html>